Will frugal innovation be what keeps healthcare systems functioning in developing and developed countries
“Procurement is not working for patients”
Will the axe swing at the ‘easy’ target of medicines as the NHS continues on its savings quest?
Smart homes to smart health
How will the new health-tech revolution help empower both patients and healthcare professionals?
Internet of Things Sales awards
Beam me up
Our must-read guide to understanding just what on earth the Internet of Things is all about
Making customers count
Who were the winners of this year’s only customer-nominated and customer-judged sales competition?
“The system works – don’t screw it up”
One man’s goal to run 100 marathons – despite being diagnosed with myeloma
Learning: the new business strategy
Learning and development should not only be a journey but part of the company culture and business strategy, says Gary Killington, director of PI Partnership
How can pharma engage directly with HCPs inside the NHS?
With so many different online resources, the internet is becoming an increasingly competitive space to engage with healthcare professionals, says Simon Grime, commercial director, Fendix Media
Click here to see the latest PharmaTimes Magazine
To subscribe go to www.pharmatimes.com/subscribe; digital available from:
Outcomes: a gamechanger for pharma
Patient-recorded outcome measures are likely to become a key part of how healthcare is provided, funded and managed. But is industry ready?
Healthcare Writer Lynne Taylor
The British government’s determination to place health outcomes at the heart of NHS decision-making presents UK-based drugmakers with a unique and potentially huge advantage over their global competitors.
Working in collaboration with the NHS to identify a product’s true value – in other words its value to the patient – has the potential to boost levels of medicines uptake and could also lead to products arriving earlier to market, both in the UK and overseas, a PharmaTimes business meeting was told recently. Leading these potentially game-changing opportunities is the NHS patient-recorded outcome measures programme, which began in 2009.
Innovative drugmakers have included PROMs in their clinical trials for many years, and the data have also long been used in observational studies and population health surveys. “We have decades of experience using these instruments and pharma is way ahead of the game. The fact they are now being measured in healthcare systems changes everything,” Professor Nancy Devlin, research director at the Office of Health Economics told the meeting. Indeed, PROMs are likely to become a key part of how all healthcare is provided, funded and managed, The King’s Fund healthcare policy think-tank has forecast.
So what exactly are PROMs and why should this matter to pharma? You can find out by reading the full article online here
See what's coming up in the March issue [PDF]
Visions 2014 supplement
Creating a balance between
reimbursement and innovation
How to plan early
What more does pharma need to do?
We asked you what the big developments in 2014 will be?
Change is key to opportunity
What to adapt for
Future-proofing the sales team
An example of a new R&D model
Visions in a nutshell
The complete Visions 2014 supplement PDF is available to download
Subscription is free to qualifying UK subscribers
To read articles in full and features in the magazine, why not subscribe
Average circulation Jan - Dec 2013: 23,178